BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

FTXHvsBMEDETF Comparison

ETF 1

FTXH

First Trust Nasdaq Pharmaceuticals ETF

This fund is part of

US Health Care

+0.69%

Full FTXH fund page

VS

ETF 2

BMED

iShares Health Innovation Active ETF

This fund is part of

Healthcare Technology

+0.67%

Full BMED fund page

First Trust Nasdaq Pharmaceuticals ETF (FTXH) belongs to the US Health Care segment. iShares Health Innovation Active ETF (BMED) is part of the Healthcare Technology segment. FTXH's top 1 sector exposures are Healthcare. In contrast, BMED's top sector exposures are Healthcare and Non-Corporate. FTXH is less expensive with a Total Expense Ratio (TER) of 0.6%, versus 0.77% for BMED. FTXH is up 31.84% year-to-date (YTD) with +$1.02B in YTD flows. BMED performs worse with 19.68% YTD performance, and +$5M in YTD flows. Run a side-by-side ETF comparison of FTXH and BMED below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios. Discover our library of Model portfolios

FTXH vs BMED performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Data Services

Historic performance and flows

Data as of 10/28/2026

		1M	3M	YTD	1Y	3Y	5Y
Perf.	FTXH BMED	+3.28%+3.51%	+9.09%+15.25%	+31.84%+19.68%	+47.80%+27.90%	+87.39%+74.02%	+77.36%+22.27%
Flows	FTXH BMED	+$41M-	+$176M+$1M	+$1.02B+$5M	+$1.02B+$6M	+$1.02B+$7M	+$1.02B+$6M

Volatility and drawdown

		3M	1Y	3Y	5Y
Volatility	FTXH BMED	+18.78%+21.53%	+17.62%+17.97%	+17.11%+16.83%	+16.43%+18.16%
Max drawdown	FTXH BMED	-5.45%-5.85%	-7.50%-14.71%	-19.32%-19.76%	-19.32%-32.14%
Max drawdown duration	FTXH BMED	57d31d	99d196d	393d237d	393d1479d

Trading data

Create an account to view trading data

Join for free

	FTXH	BMED
Last sale 10/29/2026 at 1:30 PM	$43.77	$36.72
Previous close 10/28/2026	$43.25	$36.14
Consolidated volume 10/28/2026
Average volume 30 days
Average discount or premium 30 days
Average Bid/Ask spread 30 days

Replication quality

Data as of September 30, 2026

1-year trailing difference

Create an account to view replication metrics

Join for free

BMED

is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free

	FTXH	BMED
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst

Main metrics

Last update 10/29/2026 at 1:30 PM

Live

Closed

	FTXH	BMED
Last price	$43.77	$36.72
1D performance	+1.22%	+1.62%
AuM	$1.16 B	$14.46 M
E/R	0.6%	0.77%

Characteristics

	FTXH	BMED
Management strategy	Passive	Active
Provider	First Trust	iShares
Benchmark	NASDAQ US Smart Pharmaceuticals Index	-
N° of holdings	49	53
Asset class	Equities	-
Trailing 12m distribution yield	Join	Join
Inception date	September 20, 2016	September 29, 2020
ESG	No	No

More FTXH data on Trackinsight

More BMED data on Trackinsight

Exposure

Countries

FTXH

USA

95.82%

Other

4.18%

BMED

USA

87.23%

Other

12.77%

Sectors

FTXH

Healthcare

99.79%

Other

0.21%

BMED

Healthcare

98.95%

Other

1.05%

Diversification

FTXH

Total weight of top 15 holdings out of 15

67.15%

BMED

Total weight of top 15 holdings out of 15

58.7%

Top 15 holdings

Data as of August 31, 2026

FTXH

Merck & Co., Inc.

7.62%

AbbVie, Inc.

7.05%

Eli Lilly & Co.

6.92%

Johnson & Johnson

6.87%

Bristol Myers Squibb Co.

6.75%

Amgen, Inc.

3.56%

Biogen, Inc.

3.54%

Viatris, Inc.

3.51%

Vertex Pharmaceuticals, Inc.

3.48%

Regeneron Pharmaceuticals, Inc.

3.33%

Cardinal Health, Inc.

3.29%

Pfizer Inc.

3.25%

Gilead Sciences, Inc.

3.16%

Incyte Corp.

2.43%

United Therapeutics Corp.

2.39%

BMED

Gilead Sciences, Inc.

5.01%

Merck & Co., Inc.

4.99%

AbbVie, Inc.

4.61%

Johnson & Johnson

4.27%

Charles River Laboratories International, Inc.

4.22%

Thermo Fisher Scientific, Inc.

4.12%

Edwards Lifesciences Corp.

3.95%

Moderna, Inc.

3.86%

IQVIA Holdings, Inc.

3.72%

Danaher Corp.

3.64%

Vertex Pharmaceuticals, Inc.

3.56%

Waters Corp.

3.53%

Biogen, Inc.

3.45%

Mettler-Toledo International, Inc.

3.16%

DexCom, Inc.

2.61%

Frequently asked questions about FTXH and BMED

How have the FTXH and BMED ETFs performed in 2026?

As of October 28, 2026, FTXH is up 31.84% year-to-date (YTD), while BMED has returned 19.68%. That puts FTXH better performer ahead so far this year.

Which ETF is attracting more investor money: FTXH or BMED?

Year-to-date, the FTXH ETF saw +$1.02B in flows, compared to +$5M for BMED.

Which ETF is more volatile: FTXH or BMED?

Over the past year, FTXH had a volatility of 17.62%, while BMED experienced 17.97%.

Which ETF is bigger: FTXH or BMED?

As of October 28, 2026, FTXH holds $1.16 B in assets under management (AUM), while BMED manages $14.46 M.

What sectors do the FTXH and BMED ETFs invest in?

FTXH leans toward sectors like Healthcare. Meanwhile, BMED focuses on Healthcare.

What are the top holdings of the FTXH ETF and BMED ETF?

FTXH top holdings include Merck & Co., Inc., AbbVie, Inc. and Eli Lilly & Co.. BMED holds in its top three: Gilead Sciences, Inc., Merck & Co., Inc. and AbbVie, Inc..

FTXHvsBMEDETF Comparison

First Trust Nasdaq Pharmaceuticals ETF

iShares Health Innovation Active ETF

FTXH vs BMED performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Countries

Sectors

Diversification

Top 15 holdings

How have the FTXH and BMED ETFs performed in 2026?

As of October 28, 2026, FTXH is up 31.84% year-to-date (YTD), while BMED has returned 19.68%. That puts FTXH better performer ahead so far this year.

Which ETF is attracting more investor money: FTXH or BMED?

Year-to-date, the FTXH ETF saw +$1.02B in flows, compared to +$5M for BMED.

Which ETF is more volatile: FTXH or BMED?

Over the past year, FTXH had a volatility of 17.62%, while BMED experienced 17.97%.

Which ETF is bigger: FTXH or BMED?

As of October 28, 2026, FTXH holds $1.16 B in assets under management (AUM), while BMED manages $14.46 M.

What sectors do the FTXH and BMED ETFs invest in?

FTXH leans toward sectors like Healthcare. Meanwhile, BMED focuses on Healthcare.

What are the top holdings of the FTXH ETF and BMED ETF?

FTXH top holdings include Merck & Co., Inc., AbbVie, Inc. and Eli Lilly & Co.. BMED holds in its top three: Gilead Sciences, Inc., Merck & Co., Inc. and AbbVie, Inc..

Which ETF is more diversified: FTXH or BMED?

FTXH holds 49 securities with 67.15% of its assets in the top 15. BMED has 55 securities and a top 15 weight of 58.7%.

ETFs’ Next Act: From Access to Selection